Security feature, printing ink, document of value, and manufacturing method
12545794 ยท 2026-02-10
Assignee
Inventors
Cpc classification
B41M3/144
PERFORMING OPERATIONS; TRANSPORTING
C09D11/50
CHEMISTRY; METALLURGY
B42D25/387
PERFORMING OPERATIONS; TRANSPORTING
International classification
Abstract
A security feature for safeguarding a document of value, includes an organometallic luminescent substance which, on excitation with radiation in the UV-A range, has emission of radiation in the visible wavelength range, especially with green and/or red light, wherein the luminescent substance is based on a polynuclear, heteroleptic lanthanoid complex of the formula (I) [Mx(NN ligand)a(OO ligand)b] (I) where x, a and b are natural numbers, where x2, a2 and b6; M is a lanthanoid selected from the group consisting of Eu and Th; the OO ligand is a ligand that coordinates via oxygen atoms and the NN ligand is a nitrogen ligand having a phenanthroline base skeleton.
Claims
1. A security feature for safeguarding a document of value, comprising an organometallic luminescent substance which, on excitation with radiation in a UV-A range, has emission of radiation in a visible wavelength range, wherein the luminescent substance is based on a polynuclear heteroleptic lanthanoid complex of the formula (I)
[Mx(NN ligand)a(OO ligand)b](I) where x, a and b are natural numbers, where x2, a2 and b6; M is a lanthanoid selected from the group consisting of Eu and Tb; the OO ligand is a ligand of the formula (II) that coordinates via oxygen atoms: ##STR00011## where R1 to R5 are the same or different and are independently selected from the group consisting of hydrogen atom, OH, OCH3 and halogen atom; the NN ligand is a nitrogen ligand with a phenanthroline base skeleton of the general formula (III) or of the general formula (IV) ##STR00012## where Y is NR9 or Y is an oxygen atom; R6 and R7 are the same or different and are independently selected from the group consisting of hydrogen atom and an electron-donating group; R8 and R9 are the same or different and are independently selected from the group consisting of hydrogen atom, substituted or unsubstituted alkyl radical having 1 to 8 carbon atoms, substituted or unsubstituted aryl radical, substituted or unsubstituted piperidine radical and substituted or unsubstituted benzyl radical.
2. The security feature according to claim 1, wherein the indices x, a and b in the formula (I) are subject to the relationships x=2, a=2 and b=6, in a dinuclear heteroleptic lanthanoid complex of the formula (V)
[M2(NN ligand)2(OO ligand)6](V).
3. The security feature according to claim 1, wherein the lanthanoid M in the formula (I) or in the formula (V) is the element Tb.
4. The security feature according to claim 1, wherein, in the formula (III), R6 and R7 are the same or different and are independently an electron-donating group.
5. The security feature according to claim 1, wherein, in the case that R6, R7, R8 and/or R9 is/are independently an alkyl radical, the alkyl radical is a branched or unbranched alkyl chain having 1 to 8 carbon atoms.
6. The security feature according to claim 1, wherein, in the case that R8 and/or R9 is/are independently an aryl radical, the aryl radical is selected from the group consisting of a phenyl group and a phenyl radical having 6 to 10 carbon atoms.
7. The security feature according to claim 1, wherein, in the case that R8 and/or R9 is/are independently a benzyl radical, the benzyl radical has 7 to 10 carbon atoms.
8. The security feature according to claim 1, wherein, in the case that R8 and/or R9 is/are independently a piperidine radical, the piperidine radical is a piperidine radical substituted by alkyl substituents.
9. The security feature according to claim 1, wherein the NN ligand is a nitrogen ligand having a phenanthroline base skeleton according to the general formula (IV) where Y is NR9.
10. The security feature according to claim 9, wherein R9H.
11. The security feature according to claim 1, wherein R9 is an alkyl radical, tetramethylpiperidine radical or perfluorobenzyl radical.
12. The security feature according to claim 1, wherein M=Tb and, in the formula (IV), the selection is Y=NR9 and R8=H.
13. The security feature according to claim 12, wherein R9H.
14. The security feature according to claim 12, wherein R9 is an alkyl radical, tetramethylpiperidine radical or perfluorobenzyl radical.
15. The security feature according to claim 1, wherein the OO ligand is present either as a chelate-forming ligand or as a bridging ligand between different metal centers.
16. The security feature according to claim 1, wherein the radicals of the OO ligand are chosen such that one of the five radicals is a methoxy group and the remaining four radicals are independently selected from the group consisting of hydrogen atom, OH, OCH3 and halogen atom.
17. The security feature according to claim 1, wherein the radicals of the OO ligand are chosen such that the OO ligand corresponds to a 2-methoxybenzoic acid, a 3-methoxybenzoic acid or a 4-methoxybenzoic acid.
18. The security feature according to claim 1, wherein the radicals of the OO ligand are chosen such that R5 is a hydrogen atom, R1=R3=R4 and each correspond to a hydrogen atom or a fluorine atom, and R2 is a methoxy radical.
19. The security feature according to claim 1, wherein the radicals of the OO ligand are chosen such that the OO ligand corresponds to a salicylic acid derivative.
20. A process for producing the security feature according to claim 1, comprising: a) the providing of a solution of a metal salt comprising the lanthanoid M as cation, where M is selected from the group consisting of Eu and Tb; b) the providing of a solution of the deprotonated acid of the OO ligand of the formula (II) ##STR00013## where R1 to R5 are the same or different and are independently selected from the group consisting of hydrogen atom, OH, OCH3 and halogen atom; c) the providing of a solution of the NN ligand of the general formula (III) or of the general formula (IV) ##STR00014## where Y is NR9 or Y is an oxygen atom; R6 and R7 are the same or different and are independently selected from the group consisting of hydrogen atom and an electron-donating group; R8 and R9 are the same or different and are independently selected from the group consisting of hydrogen atom, substituted or unsubstituted alkyl radical having 1 to 8 carbon atoms, substituted or unsubstituted aryl radical, substituted or unsubstituted piperidine radical and substituted or unsubstituted benzyl radical; d) the step of blending the solutions obtained in steps a), b) and c).
21. A printing ink for the printing of a document of value, wherein the printing ink comprises the security feature according to claim 1.
22. A document of value comprising the security feature according to claim 1.
23. The document of value according to claim 22, wherein the document of value is a banknote.
24. A process for producing the document of value according to claim 22, comprising: the providing of a substrate for the document of value; the printing of the substrate of the document of value with a printing ink comprising the security feature.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) Further working examples of the invention and advantages of the invention are elucidated in detail hereinafter with reference to the figures, wherein the representation dispenses with reproduction to scale and in proportion, in order to increase clarity.
(2) The figures show:
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
DETAILED DESCRIPTION OF VARIOUS EMBODIMENTS
1.1 Material and Methods
(12) The techniques used for the identification of the compounds are as follows:
(13) Evidence that the complexes of the invention are dinuclear was found by MALDI-TOF mass spectrometry (matrix-assisted laser desorption ionization). The mass spectra were recorded with an UltraFlex ToF/ToF (Bruker Daltonics). An N2 laser with wavelength 337 nm and pulse duration 3 ns was used. In linear mode the device achieves a resolution of >8000 FWHM, in reflectron mode a resolution of >20000 FWHM. The matrix used was DCTB (2-[(2E)-3-(4-tert-butylphenyl)-2-methylprop-2-enylidene]malononitrile). Mass calibration was effected immediately before sample analysis using polystyrene (Ag adduct).
(14) For all luminescent substances used in the examples, the emission spectra of the luminescent substances were measured with the aid of a Horiba Fluo-MAX 4 spectrometer.
(15) The wool scale test, also referred to later on as light test, is conducted analogously to EN ISO 105-B01:1999 in a Q-Lab xenon test chamber (Q-SUN Xe-2-H). For this purpose, the respective luminescence intensity of the prints is measured quantitatively prior to irradiation with the aid of a Horiba Fluo-MAX 4 spectrometer and normalized to 100%. The remaining residual luminescence intensity is assessed after the attainment of the wool scale points. Depending on the absorption properties of the complexes, an excitation wavelength in the UV-A range between .sub.ex=315 nm and .sub.ex=365 nm was chosen for the measurements of lightfastness. Since the residual intensities of the prints, measured at different excitation wavelengths, differ by less than 10 percentage points at all wool scale points under consideration, the lightfastness of the compounds of the invention is considered to be independent of excitation wavelength.
(16) For visual assessment of the luminescence of the luminescent complexes and prints produced, a Vilber Lourmat VL-6.LC filtered handheld UV lamp with two switchable wavelengths (=254 nm and 365 nm) was used. Luminescence color is independent of wavelength.
(17) The chemicals and reagents used were sourced from the following companies and used without further purification: 2,4,5-trifluoro-3-methoxy-benzoic acid (tfmba, Sigma-Aldrich), 3-methoxybenzoic acid (3-moba, Sigma-Aldrich), 4-methoxybenzoic acid (4-moba, Sigma-Aldrich), terbium(III) chloride hexahydrate (Sigma-Aldrich), terbium(III) nitrate pentahydrate (Auer-Remy), 1,10-phenanthroline-5,6-dione (phen-dione, abcr), 1,10-phenanthroline (phen, Merk), 1H-benzimidazole-2-carboxylic acid (HBIC, Sigma-Aldrich), 2,3,5,6-tetrafluoroterephthalic acid (TFTP, abcr), 4-sulfobenzoic acid monopotassium salt (4-SBA, Sigma-Aldrich).
1.2 Preparation of the Ligands of the Formula (III)
(18) The ligands of the formula (III), dipyrido[3,2-f:2,3-h]quinoxaline (L6), 2-methyldipyrido[3,2-f:23-h]quinoxaline (L11), cis-2,3-cyclohexane-dipyrido[3,2-f:2,3-h]quinoxaline (L8) and 2,3-dicyanodipyrido[3,2-f:2,3-h]quinoxaline (L7), were prepared analogously to example 3 of publication WO 98/049163 A1. L7 is a noninventive ligand since R6 and R7 are formed by electron-withdrawing groups.
1.3 Preparation of the Ligands of the Formula (IV)
1.3.1Synthesis of 1H-imidazo[4,5-f][1,10]phenanthroline (L1)
(19) 1,10-Phenanthroline-5,6-dione (28.617 g, 0.136 mol) was suspended in 430 ml of acetic acid and heated to 110 C. in an oil bath. Ammonium acetate (210 g, 2.72 mol) was added to the reaction solution in solid form. Then paraformaldehyde (5.720 g, 0.190 mmol) was added to the brown/orange reaction solution in solid form. The reaction mixture was stirred at 110 C. for 4 h. After cooling to room temperature, the solution was added to 200 ml of ice-water, and ammonium hydroxide solution was added until pH=7 was obtained (exothermic). In the course of this, the product precipitates out gradually. The precipitated solids were filtered off and washed with water. Drying in a drying cabinet at 60 C. gave L1 as a light ocher powder (26.99 g, 0.123 mol, 90%).
(20) Scheme 1 below shows the synthesis of 1H-imidazo[4,5-f][1,10]-phenanthroline (L1).
(21) ##STR00007##
1.3.2 General Method for Preparation of the N-Substituted Ligands of the Formula (IV) (R.SUB.8.=H, R.SUB.9.H)
(22) Variant a) for Synthesis of Ligands L4, L5, L9 and L10
(23) 1,10-Phenanthroline-5,6-dione (1 equivalent) was suspended in acetic acid (2-8 ml per mmol of phen-dione). Paraformaldehyde (1.4 equivalents), ammonium acetate (1 equivalent) and the correspondingly R.sub.9-substituted aminesee scheme 2(1.2 equivalents) were added. The reaction mixture was stirred at 90 C.-110 C. for 2-5 hours. After the reaction mixture had been cooled, ammonium hydroxide was added until pH=7 was obtained (exothermic). The precipitated solids were filtered off and washed with water. The dried crude product was suspended in ethyl acetate and filtered again. Recrystallization gave the target product as a colorless solid.
(24) Scheme 2 below shows the synthesis of the phenanthrolineimidazole derivatives L4, L5, L9 and L10 according to variant a).
(25) ##STR00008##
Variant b) for Synthesis of Ligands L2 and L3
(26) L1 (1 equivalent) was suspended in DMSO (10-30 ml per mmol of L1), and solid sodium hydroxide (1.2 equivalents) was added. After stirring at 30 C.-55 C. for 1 h, the correspondingly R.sub.9-substituted bromidesee scheme 3(1.3 equivalents) was added and the mixture was stirred at 30 C.-55 C. for a further 5 h. The reaction mixture was added to ice-water, in the course of which a pale beige solid precipitated out over time. The precipitated solid was filtered and washed with water. After recrystallization of the crude product in DCM/hexane, the target compound was obtained as a colorless powder.
(27) Scheme 3 below shows the synthesis of the phenanthrolineimidazole derivatives L2 and L3 according to variant b).
(28) ##STR00009##
1.3.3 General Method for Preparation of the 2-Substituted Ligands of the Formula (IV) L12 and L14 (R.SUB.8.H, R.SUB.9.=H)
(29) 1,10-Phenanthroline-5,6-dione (1 equivalent) was suspended in acetic acid (10-20 ml per mmol of phen-dione), ammonium hydroxide solution (15-20 equivalents) was added and the mixture was stirred at room temperature until the solution was clear. Subsequently, the appropriate aldehydesee scheme 4(1.2 equivalents) was added in solid form. The reaction mixture was stirred at 110 C. for 1-4 h. After cooling to 0 C., ammonium hydroxide solution was added to the reaction mixture until pH=7 was obtained (exothermic). The precipitated solids were filtered off and washed with water. After drying in a drying cabinet at 60 C., the target compound was obtained as a yellow or cream-colored powder.
(30) Scheme 4 below shows the synthesis of the phenanthrolineimidazole derivatives L12 and L14.
(31) ##STR00010##
1.4 General Method for Preparation of the Dinuclear Complexes
(32) All the above-described ligands were used to prepare dimeric heteroleptic terbium complexes. Two molecules of the nitrogen ligand and six molecules of the OO ligand react here with two trivalent terbium centers. For this purpose, the OO ligand was suspended in water, and the same number of moles of base (NaOH) was added. The nitrogen ligand was added to the mixture as a solution in ethanol. The metal salt terbium chloride hexahydrate was slowly added dropwise to the reaction solution as a solution in a water/ethanol mixture (1:1). This resulted in a colorless precipitate. After stirring within a temperature range of 50 C.-90 C. for 1-4 hours, the reaction mixture was cooled down to room temperature. The precipitated solids were filtered off, washed with water and dried in a drying cabinet at 60 C. The green-luminescing compounds remained as a colorless powder. In the same way, it is possible to obtain red-luminescing europium complexes using europium chloride hexahydrate.
(33) Evidence that the complexes of the invention are dinuclear was found representatively using the complexes 2, 3, 5, 7b, 7c, 10 and 17b by MALDI-TOF mass spectrometry. In all mass spectra, the main signal found was the respective molecular ion peak of a dinuclear complex of the formula (V) minus an OO ligand (referred to as [M-OO ligand]+). The loss of one or more ligands occurs during ionization and is not untypical of coordination complexes. Signals at m/z ratios that would correspond to the mononuclear complexes were not observed in any of the spectra, even allowing for the loss of one or more ligands. By way of example,
1.5 Production of the Printing Inks and Prints Thereof
(34) The complexes can be incorporated into printing ink and used directly as security features. In order to improve the printing properties, it is alternatively possible to encapsulate the dyes beforehand (core-shell pigments), as described in WO 2017/080656 A1. Processing in the polymer has only a minor effect on the properties discussed in this invention such as lightfastness (variations in the relative intensities of the wool scale points of fewer than 5 percentage points) or on the excitation spectra. Therefore, no distinction is made hereinafter between encapsulated and unencapsulated luminescent substances, and the luminescent compounds are instead referred to generally as luminescent substances.
(35) For production of printing inks, the luminescent substances 2, 3, 4, 5, 7a, 7b, 7c, 9, 10, 15, 16a, 16b, 17a, 17b, 18, 19, 20, 21, 25 (inventive) and 1, 6a, 6b, 8, 11, 12, 13, 14a, 14b, 26 (noninventive) were each incorporated into an offset printing ink (Sicpa Holding SA) with the aid of an Engelsmann JEL 25/53 pigment muller (built in 2013). The degree of pigmentation in each of the green- or red-luminescing inks was 15 percent by weight.
(36) The printing inks were printed onto security paper with an ink weight per unit area of 1 g/m.sup.2, and the prints were dried at 60 C. for 2 h. The prints are referred to hereinafter correspondingly as prints 1-26.
1.6 Inventive Complexes/Prints
1.6.1 Complex/Print 2: [Tb.SUB.2.(Tfmba).SUB.6.(L6).SUB.2.]
(37) Complex 2 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (1.129 g, 5.48 mmol) and sodium hydroxide (219 mg, 5.48 mmol) in 20 ml of water, ligand L6 (424 mg, 1.82 mmol) as a solution in 25 ml of ethanol and terbium chloride hexahydrate (681 mg, 1.82 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C. Yield: 78%. MS/MALDI (DCTB, positive): m/z (isotope peak) (%)=1806.9 (100) [Mtfmba].sup.+ calc. for [C.sub.68H.sub.36F.sub.15N.sub.8O.sub.15Tb.sub.2].sup.+=1807.1
(38) Print 2 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=356 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.2 Complex/Print 3: [Tb.SUB.2.(3-moba).SUB.6.(L6).SUB.2.]
(39) Complex 3 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (963 mg, 6.33 mmol) and sodium hydroxide (253 mg, 6.33 mmol) in 25 ml of water, ligand L6 (490 mg, 2.11 mmol) as a solution in 25 ml of ethanol and terbium chloride hexahydrate (787 mg, 2.11 mmol) as a solution in a water/ethanol mixture (1:1) at 70 C. Yield: 87%. MS/MALDI (DCTB, positive): m/z (isotope peak) (%)=1537.2 (100) [M3-moba].sup.+ calc. for [C.sub.68H.sub.51N.sub.8O.sub.15Tb.sub.2].sup.+=1537.2
(40) Print 3 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=356 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.3 Complex/Print 4: [Tb.SUB.2.(tfmba).SUB.6.(L11).SUB.2.]
(41) Complex 4 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (1.352 g, 6.55 mmol) and sodium hydroxide (262 mg, 6.55 mmol) in 40 ml of water, ligand L11 (514 mg, 2.18 mmol) as a solution in 50 ml of ethanol and terbium chloride hexahydrate (817 mg, 2.18 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C. Yield: 77%.
(42) Print 4 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=356 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.4 Complex/Print 5: [Tb.SUB.2.(tfmba).SUB.6.(L8).SUB.2.]
(43) Complex 5 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (880 mg, 4.26 mmol) and sodium hydroxide (171 mg, 4.26 mmol) in 40 ml of water, ligand L8 (408 mg, 1.42 mmol) as a solution in 50 ml of ethanol and terbium chloride hexahydrate (531 mg, 1.42 mmol) as a solution in a water/ethanol mixture (1:1) at 90 C. Yield: 86%. MS/MALDI (DCTB, positive): m/z (isotope peak) (%)=1915.2 (100) [M-tfmba].sup.+ calc. for [C.sub.76H.sub.48F.sub.15N.sub.8O.sub.15Tb.sub.2].sup.+=1915.2
(44) Print 5 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=363 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.5 Complexes/Prints 7a/b/c: [Tb.SUB.2.(OO Ligand).SUB.6.(L1).SUB.2.]
(45) 7a) OO ligand=tfmba, 7b) OO ligand=3-moba, 7c) OO ligand=4-moba
(46) Complex 7a was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (675 mg, 3.27 mmol) and sodium hydroxide (131 mg, 3.27 mmol) in 20 ml of water, ligand L1 (241 mg, 1.09 mmol) as a solution in 50 ml of ethanol and terbium chloride hexahydrate (408 mg, 1.09 mmol) as a solution in a water/ethanol mixture (1:1) at 70 C. Yield: 74%.
(47) Print 7a under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=398 nm has green emission with an emission maximum of .sub.em=544 nm.
(48) Complex 7b was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (701 mg, 4.61 mmol) and sodium hydroxide (184 mg, 4.61 mmol) in 20 ml of water, ligand L1 (338 mg, 1.53 mmol) as a solution in 60 ml of ethanol and terbium chloride hexahydrate (573 mg, 1.53 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C. Yield: 71%. MS/MALDI (DCTB, positive): m/z (isotope peak) (%)=1513.5 (100) [M3-moba].sup.+ calc. for [C.sub.66H.sub.51N.sub.8O.sub.15Tb.sub.2].sup.+=1513.2
(49) Print 7b under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=397 nm has green emission with an emission maximum of .sub.em=544 nm.
(50) Complex 7c was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 4-methoxybenzoic acid (1.94 g, 12.8 mmol) and 12.8 ml of 1 N aqueous sodium hydroxide solution in 100 ml of water, ligand L1 (937 mg, 4.26 mmol) as a solution in 200 ml of ethanol and terbium chloride hexahydrate (1.59 g, 4.26 mmol) as a solution in a water/ethanol mixture (1:1) at 70 C. Yield: 59%. MS/MALDI (DCTB, positive): m/z (isotope peak) (%)=1513.4 (100) [M4-moba].sup.+ calc. for [C.sub.66H.sub.51N.sub.8O.sub.15Tb.sub.2].sup.+=1513.2
(51) Print 7c under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=395 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.6 Complex/Print 9: [Eu.SUB.2.(Tfmba).SUB.6.(L6).SUB.2.]
(52) Complex 9 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (944 mg, 4.58 mmol) and sodium hydroxide (183 mg, 4.58 mmol) in 20 ml of water, ligand L6 (354 mg, 1.53 mmol) as a solution in 60 ml of ethanol and europium chloride hexahydrate (550 mg, 1.53 mmol) as a solution in a water/ethanol mixture (1:1) at 70 C. Yield: 95%.
(53) Print 9 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=356 nm has red emission with an emission maximum of .sub.em=612 nm.
1.6.7 Complex/Print 10: [Eu.SUB.2.(3-Moba).SUB.6.(L1).SUB.2.]
(54) Complex 10 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (831 mg, 5.46 mmol) and sodium hydroxide (218 mg, 5.46 mmol) in 10 ml of water, ligand L1 (400 mg, 1.82 mmol) as a solution in 150 ml of ethanol and europium chloride hexahydrate (667 mg, 1.82 mmol) as a solution in a water/ethanol mixture (1:1) at 70 C. Yield: 70%. MS/MALDI (DCTB, positive): m/z (isotope peak) (%)=1499.2 (100) [M3-moba].sup.+ calc. for [C.sub.66H.sub.51Eu.sub.2N.sub.8O.sub.15].sup.+=1499.2
(55) Print 10 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=398 nm has red emission with an emission maximum of .sub.em=611 nm.
1.6.8 Complex/Print 15: [Tb.SUB.2.(3-Moba).SUB.6.(L2).SUB.2.]
(56) Complex 15 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (202 mg, 1.33 mmol) and 2.4 ml of 1 N aqueous sodium hydroxide solution in 3 ml of water, ligand L2 (177 mg, 0.44 mmol) as a solution in 16 ml of ethanol and terbium chloride hexahydrate (165 mg, 0.44 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C. Yield: 75%.
(57) Print 15 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=391 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.9 Complexes/Prints 16a/b: [Tb.SUB.2.(OO Ligand).SUB.6.(L3).SUB.2.]
(58) 16a) OO ligand=tfmba, 16b) OO ligand=3-moba
(59) Complex 16a was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (2.87 g, 13.9 mmol) and 13.9 ml of 1 N aqueous sodium hydroxide solution in 4 ml of water, ligand L3 (1.44 g, 4.65 mmol) as a solution in 40 ml of ethanol and terbium chloride hexahydrate (1.74 g, 4.65 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C. Yield: 95%.
(60) Print 16a under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=395 nm has green emission with an emission maximum of .sub.em=545 nm.
(61) Complex 16b was prepared in the same way with 3-methoxybenzoic acid (735 mg, 4.83 mmol) as OO ligand. Yield: 85%.
(62) Print 16b under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=396 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.10 Complexes/prints 17a/b: [Tb.SUB.2.(OO ligand).SUB.6.(L4).SUB.2.]
(63) 17a) OO ligand=tfmba, 17b) OO ligand=3-moba
(64) Complex 17a was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (835 mg, 4.05 mmol) and 4 ml of 1 N aqueous sodium hydroxide solution in 20 ml of water, ligand L4 (373 mg, 1.35 mmol) as a solution in 80 ml of ethanol and terbium chloride hexahydrate (504 mg, 1.35 mmol) as a solution in a water/ethanol mixture (1:1) at 80 C. Yield: 86%.
(65) Print 17a under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=396 nm has green emission with an emission maximum of .sub.em=545 nm.
(66) Complex 17b was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (2.93 g, 19.2 mmol) and 19.2 ml of 1 N aqueous sodium hydroxide solution in 30 ml of water, ligand L4 (1.77 g, 6.4 mmol) as a solution in 100 ml of ethanol and terbium chloride hexahydrate (2.39 g, 6.4 mmol) as a solution in a water/ethanol mixture (1:1) at 70 C. Yield: 95%. MS/MALDI (DCTB, positive): m/z (isotope peak) (%)=1625.2 (100) [M3-moba].sup.+ calc. for [C.sub.74H.sub.67N.sub.8O.sub.15Tb.sub.2].sup.+=1625.3
(67) Print 17b under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=397 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.11 Complex/Print 18: [Tb.SUB.2.(3-moba).SUB.6.(L5).SUB.2.]
(68) Complex 18 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (1.04 g, 6.85 mmol) and 6.85 ml of 1 N aqueous sodium hydroxide solution in 20 ml of water, ligand L5 (759 mg, 2.28 mmol) as a solution in 50 ml of ethanol and terbium chloride hexahydrate (852 mg, 2.28 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C. Yield: 66%.
(69) Print 18 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=397 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.12 Complex/Print 19: [Tb.SUB.2.(3-moba).SUB.6.(L9).SUB.2.]
(70) Complex 19 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (2.08 g, 13.6 mmol) and 13.6 ml of 1 N aqueous sodium hydroxide solution in 10 ml of water, ligand L9 (1.63 g, 4.54 mmol) as a solution in 30 ml of ethanol and terbium chloride hexahydrate (1.70 g, 4.54 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C. Yield: 48%.
(71) Print 19 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=400 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.13 Complex/Print 20: [Tb.SUB.2.(3-moba).SUB.6.(L10).SUB.2.]
(72) Complex 20 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (2.52 g, 16.5 mmol) and 16.5 ml of 1 N aqueous sodium hydroxide solution in 13 ml of water, ligand L10 (1.95 g, 5.51 mmol) as a solution in 55 ml of ethanol and terbium chloride hexahydrate (2.06 g, 5.51 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C. Yield: 87%.
(73) Print 20 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=392 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.14 Complex/Print 21: [Tb.SUB.2.(tfmba).SUB.6.(L12).SUB.2.]
(74) Complex 21 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (1.0154 g, 4.93 mmol) and sodium hydroxide (197 mg, 4.93 mmol) in 25 ml of water, L12 (454 mg, 1.64 mmol) as a solution in 100 ml of ethanol and terbium chloride hexahydrate (613 mg, 1.64 mmol) as a solution in a water/ethanol mixture (1:1) at 70 C. Yield: 74%.
(75) Print 21 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=414 nm has green emission with an emission maximum of .sub.em=545 nm.
1.6.15 Complex/Print 25: [Eu.SUB.2.(3-moba).SUB.6.(L14).SUB.2.]
(76) Complex 25 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (217 mg, 1.43 mmol) and sodium hydroxide (57 mg, 1.43 mmol) in 15 ml of water, ligand L14 (150 mg, 0.48 mmol) as a solution in 40 ml of ethanol and europium chloride hexahydrate (176 mg, 0.48 mmol) as a solution in a water/ethanol mixture (1:1) at 80 C. Yield: 25%.
(77) Print 25 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=433 nm has green emission with an emission maximum of .sub.em=614 nm.
1.7 Noninventive Complexes/Prints
1.7.1 Complex/Print 1 (Mononuclear; no OO Ligand): [Tb(L6).SUB.2.Cl.SUB.3.]
(78) Ligand L6 (928 mg, 3.99 mmol) was suspended in 320 ml of acetonitrile and heated to 80 C. Terbium chloride hexahydrate (745 mg, 1.99 mmol) was added to the reaction solution in solid form, and the reaction mixture was heated to reflux for 12 h. After cooling to room temperature, a colorless precipitate flocculated out. The precipitated solid was filtered off, washed with water and then dried. 1.34 g of complex 1 was obtained.
(79) Print 1 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=360 nm has green emission with an emission maximum of .sub.em=543 nm.
1.7.2 Complex/Print 26 (Mononuclear; no OO Ligand): [Eu(L6).SUB.2.Cl.SUB.3.]
(80) Ligand L6 (300 mg, 1.29 mmol) was suspended in 150 ml of acetonitrile and heated to 80 C. Europium chloride hexahydrate (236 mg, 0.65 mmol) was added to the reaction solution in solid form, and the reaction mixture was heated to reflux for 4 h. After cooling to room temperature, a colorless precipitate flocculated out. The precipitated solid was filtered off, washed with water and then dried. 400 mg of complex 26 was obtained.
(81) Print 26 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=371 nm has green emission with an emission maximum of .sub.em=615 nm.
1.7.3 Complexes/Prints 14a/b (Mononuclear, no OO Ligand): 14a [Tb(L1).SUB.3.] and 14b [Tb(L1).SUB.2.Cl]
(82) Ligand L1 (445 mg, 2.02 mmol) was suspended in a mixture of 20 ml of water and 25 ml of EtOH, and aqueous 1 N NaOH solution was added until the ligand dissolved. Terbium chloride hexahydrate (251 mg, 0.672 mmol) was added to the reaction mixture in solid form, and the reaction mixture was heated at 80 C. for 3 h. 480 mg of complex 14a was obtained. Complex 14b was prepared in the same way with a ligand/metal salt ratio of 2:1.
(83) Prints 14a and 14b do not show any visually perceptible luminescence under illumination with UV light.
1.7.4 Complexes/prints 6a/b (NN ligand does not conform to formula (III) or (IV)): [Tb.SUB.2.(OO ligand).SUB.6.(phen).SUB.2.] (phen=1,10-phenanthroline)
(84) 6a) OO ligand=tfmba, 6b) OO ligand=3-moba
(85) Complex 6a was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (1.043 g, 5.06 mmol) and sodium hydroxide (202 mg, 5.06 mmol) in 30 ml of water, 1,10-phenanthroline (303 mg, 1.69 mmol) as a solution in 30 ml of ethanol and terbium chloride hexahydrate (631 mg, 1.69 mmol) as a solution in a water/ethanol mixture (1:1) at 90 C. Yield: 63%.
(86) Print 6a under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=335 nm has green emission with an emission maximum of .sub.em=544 nm.
(87) Complex 6b was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 3-methoxybenzoic acid (2.612 g, 17.16 mmol) and sodium hydroxide (686 mg, 17.16 mmol) in 80 ml of water, 1,10-phenanthroline (1.031 g, 5.72 mmol) as a solution in 100 ml of ethanol and terbium chloride hexahydrate (2.137 mg, 5.72 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C. Yield: 90%.
(88) Print 6b under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=336 nm has green emission with an emission maximum of .sub.em=544 nm.
1.7.5 Complex/Print 8 (NN Ligand of the Formula (III), but with Electron-Withdrawing Radicals R.SUB.6/7.): [Tb.SUB.2.(tfmba).SUB.6.(L7).SUB.2.]
(89) Complex 8 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 2,4,5-trifluoro-3-methoxybenzoic acid (415 mg, 2.01 mmol) and sodium hydroxide (80 mg, 2.01 mmol) in 40 ml of water, ligand L7 (192 mg, 0.67 mmol) as a solution in 100 ml of ethanol and terbium chloride hexahydrate (251 mg, 0.67 mmol) as a solution in a water/ethanol mixture (1:1) at 60 C.
(90) Print 8 does not show any visually perceptible luminescence under illumination with UV light.
1.7.6 Complex/Print 11 (OO Ligand does not Conform to Formula (II)): [Tb.SUB.2.(HBIC).SUB.6.(L6).SUB.2.]
(91) Complex 11 was prepared by the general method for preparation of dimeric complexes proceeding from a solution of 1H-benzimidazole-2-carboxylic acid (518 mg, 3.19 mmol) and 3.19 ml of 1 N aqueous sodium hydroxide solution, ligand L6 (247 mg, 1.06 mmol) as a solution in 30 ml of ethanol and terbium chloride hexahydrate (398 mg, 1.06 mmol) as a solution in a water/ethanol mixture (1:1) at 70 C. Yield: 76%.
(92) Print 11 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=372 nm has green emission with an emission maximum of .sub.em=543 nm.
1.7.7 Complex/Print 12 (OO Ligand does not Conform to Formula (II)): [Tb.SUB.2.(TFTP).SUB.3.(L1).SUB.2.]
(93) 2,3,5,6-Tetrafluoroterephthalic acid (964 mg, 4.05 mmol) was suspended in 100 ml of water, and 8.1 ml of 1 N aqueous sodium hydroxide solution was added. Ligand L1 (446 mg, 2.02 mmol) was added as a solution in 105 ml of ethanol and the reaction solution was heated to 100 C. Terbium chloride hexahydrate (756 mg, 2.025 mmol) was slowly added dropwise as a solution in a water/ethanol mixture (1:1) and the reaction solution was stirred at 100 C. for 30 min and then at room temperature overnight. The precipitated solid was filtered off, washed with water and then dried. Yield: 75%.
(94) Print 12 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=403 nm has green emission with an emission maximum of .sub.em=544 nm.
1.7.8 Complex/Print 13 (OO Ligand does not Conform to Formula (II)): [Tb.SUB.2.(4-SBA).SUB.3.(L1).SUB.2.]
(95) 4-Sulfobenzoic acid monopotassium salt (704 mg, 2.93 mmol) was suspended in 10 ml of water, and 3.9 ml of 1 N aqueous sodium hydroxide solution was added. Ligand L1 (431 mg, 1.95 mmol) was added as a solution in 20 ml of water and 40 ml of ethanol. Terbium(III) nitrate pentahydrate (850 mg, 1.95 mmol), dissolved in 10 ml of water, was slowly added dropwise and the reaction solution was stirred at room temperature for 6 h. The precipitated solid was filtered, washed with water and then dried. Yield: 77%.
(96) Print 13 under illumination with UV light of wavelengths .sub.ex=240 nm to .sub.ex=408 nm has green emission with an emission maximum of .sub.em=545 nm.
2. Tabular Overview of the Prints
(97) TABLE-US-00001 TABLE 1 Position of excitation spectra and remaining residual intensities of luminescence after the attainment of the wool scale points (lightfastness) of illustrative dimeric Tb and Eu complexes with different OO and NN ligands. Band edge of excitation spectrum OO NN (25% int.)/ Designation Lanthanoid ligand ligand nm WS0 WS1 WS2 WS3 WS4 inventive Print 2 Tb tfmba L6 348 100% 88% 85% 78% 63% Print 3 Tb 3-moba L6 349 100% 89% 83% 75% 61% Print 4 Tb tfmba L11 351 100% 80% 76% 74% 58% Print 5 Tb tfmba L8 358 100% 81% 75% 63% 46% Print 7a Tb tfmba L1 388 100% 73% 63% 46% 32% Print 7b Tb 3-moba L1 386 100% 69% 58% 47% 31% Print 7c Tb 4-moba L1 378 100% 62% 53% 43% 31% Print 9 Eu tfmba L6 348 100% 94% 85% 70% 72% Print 10 Eu 3-moba L1 388 100% 96% 97% 88% 79% noninventive Print 1 Tb L6 353 100% 59% 47% 37% 26% Print 26 Eu L6 360 100% 69% 60% 54% 43% Print 14a/b Tb L1 no luminescence Print 6a Tb tfmba phen 313 100% 97% 92% 89% 79% Print 6b Tb 3-moba phen 325 100% 99% 93% 83% 75% Print 8 Tb tfmba L7 no luminescence Print 11 Tb HBIC L6 363 100% 25% Print 12 Tb TFTP L1 397 100% 48% 40% 31% 23% Print 13 Tb 4-SBA L1 396 100% 39% 31% 27% 22%
(98) TABLE-US-00002 TABLE 2 Position of excitation spectra and remaining residual intensities of luminescence after the attainment of the wool scale points (lightfastness) of illustrative dimeric Tb and Eu complexes with NN ligands of the formula (IV). Band edge of excitation spectrum OO NN (25% int.)/ Designation Lanthanoid ligand ligand R.sup.8 R.sup.9 nm WS0 WS1 WS2 WS3 WS4 inventive Print 15 Tb 3-moba L2 H pentafluoro- 376 100% 89% 85% 77% 65% benzyl Print 16a Tb tfmba L3 H benzyl 385 100% 76% 73% 61% 47% Print 16b Tb 3-moba L3 H benzyl 385 100% 97% 93% 79% 61% Print 17a Tb tfmba L4 H n-butyl 385 100% 79% 72% 61% 48% Print 17b Tb 3-moba L4 H n-butyl 385 100% 80% 74% 64% 46% Print 18 Tb 3-moba L5 H n-octyl 385 100% 88% 77% 66% 50% Print 19 Tb 3-moba L9 H HALS* 390 100% 81% 77% 70% 61% Print 20 Tb 3-moba L10 H p-tert- 381 100% 87% 85% 66% 18% butyl-phenyl Print 21 Tb tfmba L12 tert-butyl H 402 100% 65% 55% 39% 24% Print 25 Eu 3-moba L14 4-fluoro- H 422 100% 94% 87% 79% 63% phenyl *2,2,6,6-tetramethylpiperidine
3. Example 1: Comparison of Mononuclear and Dinuclear Complexes
(99) By virtue of the provision of inventive dinuclear complexes (prints 2 and 3) by comparison with a mononuclear terbium complex (print 1) each having the same nitrogen ligands, an improvement is surprisingly found in lightfastness without significant effects on the excitation spectrum (see
(100)
(101) This behavior is independent of the lanthanoid used. The dinuclear europium complex (print 9) shows distinctly better lightfastness compared to the mononuclear complex having the same NN ligand L6 (print 26).
(102) In addition, it is a feature of the luminescent substances of the invention that the use of the bridging OO ligands brings the lanthanoid metal centers spatially close to one another, and hence reduces the probability of energy back-transfer from the metal (metal center) to the ligand or energy loss via radiationless deactivation (vibronic relaxation). It is thus possible to utilize particular NN ligands as sensitizers that do not have efficient energy transfer to the metal center without OO co-ligands.
(103) The mononuclear Tb complexes 14a and 14b with L1 as NN ligand do not show any visually perceptible luminescence under illumination with UV light. However, the inventive dinuclear complexes 7a and 7b with the same NN ligand (L1) luminesce in the green under illumination with UV light.
4. Example 2: Comparison of different OO ligands
(104) If noninventive OO ligands are used in dinuclear complexes (complexes 11-13), the prints have lower lightfastness than the dinuclear complexes with the corresponding NN ligands and inventive OO ligands (complexes 2, 3 and 7).
5. Example 3: Comparison of different NN ligands
(105) The excitation spectrum is influenced by the choice of NN ligand. Thus, an increase in 71 electron density by extension of the conjugated electron system in the NN ligand (cf. print 6 (counterexample), print 2/3 (extension of the electron system with electron-deficient heterocycle) and print 7 (extension of the electron system with electron-rich heterocycle) lead to a shift in the excitation spectrum into the bathochromic wavelength range. A bathochromic shift in the excitation spectrum within the UV-A range is desirable since most document testing devices are equipped with UV light sources having an illumination maximum at =365 nm. The inventive prints 2/3 and 7, by contrast with the noninventive print 6, are excitable in the UV-A range (see
(106)
6. Example 4: Comparison of Different Substituents R.SUB.6 .and R.SUB.7
(107) It is a feature of the luminescent substances of the invention that the introduction of specific substituents R.sub.6 and R.sub.7 having an electron-donating effect can shift the excitation spectrum into the bathochromic region. With, for example, R.sub.6=H and R.sub.7=methyl (print 4) or R.sub.6 and R.sub.7 combined to form a 6-membered cyclohexyl radical (print 5), the excitation maximum in the UV-A range is at =343 nm (print 4) or at =350 nm (print 5). By comparison, the excitation maximum of print 2 with R.sub.6=R.sub.7=H is at =338 nm.
(108)
(109) As well as the shift in the excitation spectrum, a further surprising effect has occurred. To wit, the visual brightness of the luminescence of the prints increases from 2 through 4 to 5. This is illustrated by the spectrally integrated excitation spectra of the individual prints (=240 nm-400 nm). The excitation spectra measured are spectrally integrated here in order to obtain a measure of visual brightness. Since the emission maximum is the same for all luminescent spectra, this was chosen for measurement of the excitation spectra. The visual brightness of prints 4 and 5 was divided by the visual brightness of the reference print (print 2) in order to obtain the relative visual brightness of prints 4 and 5.
(110)
(111) If the ligand of the formula (III) is substituted by electron-withdrawing radicals (not in accordance with the invention, e.g. R.sub.6/7=CN (ligand L7)complex 8) rather than with electron-donating radicals as in example 3 (complexes 4 and 5), the dimeric complexes do not luminesce. The yellow-brown solid of the [Tb.sub.2(tfmba).sub.6(L7).sub.2] form (complex 8) obtained after the synthesis, under illumination with UV light, does not show any visually perceptible luminescence.
(112) For the inventive compounds, R.sub.6 and R.sub.7 must comprise electron-donating radicals, for example alkyl chains.
7. Example 5: Comparison of Different Substituents R.SUB.8 .and R.SUB.9
(113) It is possible via the choice of substituents R.sub.8 and R.sub.9 of the dinuclear complexes of the general formula (V) having NN ligands of the formula (IV) to vary properties such as lightfastness and excitability of the luminescent substances. Lightfastness is adjustable via the choice of substituent R.sub.9. The excitation spectrum can be influenced via the choice of substituent R.sub.8.
(114) If the ligand of the formula (IV) is substituted on the nitrogen (R.sub.9H), lightfastness is surprisingly distinctly improved compared to the complex with an unsubstituted NN ligand (prints 15-20 by comparison with prints 7a/b). It is also possible to adjust the quality of lightfastness by choice of the R.sub.9 substituent (WS4 between 46% and 65%). The R.sub.9 substituent has no significant effect on the excitation spectrum (see
(115) This is different in the case of substitution in the 2 position (R.sub.8): it is possible here depending on the choice of substituent to achieve distinct broadening of the excitation band into the bathochromic region (see
(116)
(117)
(118)